These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22982546)

  • 1. E1A expression might be controlled by miR-214 in cells with low adenovirus productivity.
    Yanagawa-Matsuda A; Kitamura T; Higashino F; Yamano S; Totsuka Y; Shindoh M
    Virus Res; 2012 Dec; 170(1-2):85-90. PubMed ID: 22982546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
    Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
    Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
    Watanabe Y; Hashimoto Y; Kagawa S; Kawamura H; Nagai K; Tanaka N; Urata Y; Fujiwara T
    Cancer Gene Ther; 2012 Nov; 19(11):767-72. PubMed ID: 22956040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.
    Saito Y; Sunamura M; Motoi F; Abe H; Egawa S; Duda DG; Hoshida T; Fukuyama S; Hamada H; Matsuno S
    Cancer Gene Ther; 2006 Mar; 13(3):242-52. PubMed ID: 16179928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
    Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
    Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of adenovirus E1A mRNA by RNAi results in enhanced recombinant protein expression in transiently transfected HEK293 cells.
    Hacker DL; Bertschinger M; Baldi L; Wurm FM
    Gene; 2004 Oct; 341():227-34. PubMed ID: 15474305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
    Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function.
    Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C
    Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E1A genes of adenovirus type 2 and type 5 are expressed at different levels.
    Möritz C; Dobbelstein M
    Arch Virol; 2006 Jun; 151(6):1085-92. PubMed ID: 16421637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
    Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter strength in adenovirus transducing vectors: down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction.
    Schaack J; Allen B; Orlicky DJ; Bennett ML; Maxwell IH; Smith RL
    Virology; 2001 Dec; 291(1):101-9. PubMed ID: 11878880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cells arrest in S phase in response to adenovirus 12 E1A.
    Grand RJ; Ibrahim AP; Taylor AM; Milner AE; Gregory CD; Gallimore PH; Turnell AS
    Virology; 1998 May; 244(2):330-42. PubMed ID: 9601504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells.
    Hibma MH; Real NC; Wiles A; Dobson-Le D; Dix BR; Wynford-Thomas D; Braithwaite AW; Royds JA
    Virus Res; 2009 Oct; 145(1):112-20. PubMed ID: 19576936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
    Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
    Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.